Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) EPS (Weighted Average and Diluted) (2016 - 2026)

MedWellAI has reported EPS (Weighted Average and Diluted) over the past 10 years, most recently at -$0.05 for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 16.67% to -$0.05 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.28 through Dec 2025, down 300.0% year-over-year, with the annual reading at -$0.49 for FY2025, 77.52% up from the prior year.
  • EPS (Weighted Average and Diluted) was -$0.05 for Q4 2025 at MedWellAI, up from -$0.09 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.11 in Q2 2024 and troughed at -$9.75 in Q2 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.08 (2024), against an average of -$0.67.
  • Year-over-year, EPS (Weighted Average and Diluted) surged 222.67% in 2021 and then crashed 31225.59% in 2022.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.0 in 2021, then crashed by 31225.59% to -$0.7 in 2022, then skyrocketed by 81.43% to -$0.13 in 2023, then skyrocketed by 53.85% to -$0.06 in 2024, then increased by 16.67% to -$0.05 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's EPS (Weighted Average and Diluted) are -$0.05 (Q4 2025), -$0.09 (Q3 2025), and -$0.04 (Q2 2025).